Last reviewed · How we verify

Sevoflurane intravenous anesthesia — Competitive Intelligence Brief

Sevoflurane intravenous anesthesia (Sevoflurane intravenous anesthesia) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Volatile anesthetic. Area: Anesthesiology.

phase 3 Volatile anesthetic GABA_A receptor Anesthesiology Small molecule Live · refreshed every 30 min

Target snapshot

Sevoflurane intravenous anesthesia (Sevoflurane intravenous anesthesia) — The Cleveland Clinic. Sevoflurane acts as a general anesthetic by modulating the activity of the GABA_A receptor, leading to a decrease in neuronal excitability.

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Sevoflurane intravenous anesthesia TARGET Sevoflurane intravenous anesthesia The Cleveland Clinic phase 3 Volatile anesthetic GABA_A receptor
The midazolam ketamine group The midazolam ketamine group Kasr El Aini Hospital phase 3 Benzodiazepine and NMDA receptor antagonist GABA_A receptor, NMDA receptor
Remifentanil and/or propofol Remifentanil and/or propofol Alder Hey Children's NHS Foundation Trust phase 3 Opioid analgesic, Sedative-hypnotic Opioid receptors, GABA_A receptor
Propofol-Lipuro Propofol-Lipuro University Hospital, Grenoble phase 3 GABA receptor agonist GABA_A receptor
propofol (drug) propofol (drug) B. Braun Melsungen AG phase 3 GABA receptor agonist GABA_A receptor
Stiripentol Oral Capsule Stiripentol Oral Capsule Biocodex phase 3 GABA_A receptor modulator GABA_A receptor
topiramate, propranolol topiramate, propranolol Johnson & Johnson Pharmaceutical Research & Development, L.L.C. phase 3 Anticonvulsant Voltage-dependent sodium channels, GABA_A receptor

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Volatile anesthetic class)

  1. Medical University of Gdansk · 2 drugs in this class
  2. Assistance Publique - Hôpitaux de Paris · 1 drug in this class
  3. Federal University of São Paulo · 1 drug in this class
  4. King's College Hospital NHS Trust · 1 drug in this class
  5. London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's · 1 drug in this class
  6. The Cleveland Clinic · 1 drug in this class
  7. University Hospital, Basel, Switzerland · 1 drug in this class
  8. Asan Medical Center · 1 drug in this class
  9. University Hospital, Clermont-Ferrand · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Sevoflurane intravenous anesthesia — Competitive Intelligence Brief. https://druglandscape.com/ci/sevoflurane-intravenous-anesthesia. Accessed 2026-05-16.

Build your own brief

Pick any drug + add comparators: